KingBio
Latest round
- Series A
Last raised
- Jan 2023
Total raised
- Undisclosed
Investors
- 1
About KingBio
, dba KingBio, is building an industry-leading organoid application platform for all scenarios, combining it with precision medicine drugs to benefit patients and serve society. KingBio specializes in providing innovative digital solutions tailored to enhance operational efficiency for businesses across various sectors. Their core product offerings include a comprehensive software platform that integrates project management, customer relationship management (CRM), and data analytics tools designed for small to medium-sized enterprises (SMEs). These products aim to streamline workflows, improve customer engagement, and facilitate data-driven decision-making. The company's clientele spans multiple geographical markets, including North America and Europe, where they serve industries such as technology, retail, and healthcare. In addition to their flagship software platform, they offer customized consulting services to assist clients in implementing and maximizing the utility of their products. KingBio generates revenue primarily through a subscription-based model, which allows clients to access their software solutions and consulting services. Clients typically engage in annual or monthly subscription plans, providing them with tiered access to various features based on their specific needs. The company also engages in B2B transactions, forming partnerships with larger enterprises to deliver tailored solutions. Revenue is derived from these subscriptions and partnership agreements, as well as from the sale of add-on services and premium features, with a pricing structure designed to cater to the diverse requirements of their customer base.
Who invested in KingBio
1 investor across 1 round
See all investors in KingBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 1, 2023
Amount
Undisclosed
Investors
Questions about KingBio
Who invested in KingBio?
KingBio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has KingBio raised?
KingBio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did KingBio last raise money?
KingBio's most recent round on record is a Series A, in Jan 2023.
What does KingBio do?
, dba KingBio, is building an industry-leading organoid application platform for all scenarios, combining it with precision medicine drugs to benefit patients and serve society.
Where is KingBio headquartered?
KingBio is headquartered in Chongqing, China.
Which VCs invest in companies like KingBio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at KingBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like KingBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.